CORESMA

COVID-19-Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research

Prof Gérard Krause, Head of the Department Epidemiology at the HZI, is the coordinator of the CORESMA consortium, which is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003480.

Among the biggest challenges in the COVID-19 outbreak are the lack of triangulation of clinical, epidemiologic and immunological information for evidence-based response strategies. Our overriding ambition is to overcome this deficit through field studies and implementation research in specific populations early enough to already serve in the response to the current outbreak.

Four technical work packages (WPs) address the four main objectives:

• To provide real-time clinical data to improve risk assessment and response, deploying an established mHealth Surveillance Outbreak Response Management and Analysis System (SORMAS) in Nepal, Ivory Coast, Ghana and Nigeria; countries likely to be affected more intensively than the EU (WP I, Lead: Gérard Krause, HZI).
• To implement differential serolomics (multiplex serology) for population serum samples from Germany and Nepal for investigating pre-existing cross or partial immunity against COVID-19 and impact on susceptibility (WP II, Lead: Nicole Schneiderhan-Marra, NMI).
• To apply comprehensive modelling, sampling and artificial intelligence on data from the first two work packages in order to assess predictors for severe outcome, transmission dynamics and intervention effectiveness (WP III, Lead: Mirjam Kretzschmar, RIVM).
• To measure and improve quality of epidemic containment measures through implementation research in countries particularly vulnerable to the COVID-19 epidemic, in order to tailor effective and efficient control measures to health systems realities in Nepal and Ivory Coast, and to reduce the intensity of importation into the EU (WP IV, Lead: Kaspar Wyss, TPH).

The consortium combines an accelerated ad-hoc outbreak response to address the urgency and a sustainable strategy to serve beyond the current public health threat from COVID-19. Software maturity, established networks, pre-approval investments and interdisciplinary expertise among partners - including first hand from China - shall generate first findings within weeks, such as validated criteria for high-risk groups, effectiveness of contact tracing, set-up serolomics platform.                                         

Partner

National Institute for Public Health and the Environment (RIVM)
Swiss Tropical and Public Health Institute (SwissTPH)
Natural and Medical Sciences Institute, University Tübingen (NMI)
College of Life Science and Technology, Beijing University of Chemical Technology (BUCT)
Epidemiology and Disease Control Division (EDCD), Department of Health Services, Ministry of Health and Population (MOHP)
Ministry of Health and Public Hygiene, Republic of Côte d’Ivoire (INHP)